Makito Yaegashi

1.0k total citations
30 papers, 722 citations indexed

About

Makito Yaegashi is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Makito Yaegashi has authored 30 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Infectious Diseases. Recurrent topics in Makito Yaegashi's work include Pneumonia and Respiratory Infections (17 papers), Respiratory viral infections research (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Makito Yaegashi is often cited by papers focused on Pneumonia and Respiratory Infections (17 papers), Respiratory viral infections research (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Makito Yaegashi collaborates with scholars based in Japan, United States and Switzerland. Makito Yaegashi's co-authors include Konosuke Morimoto, Motoi Suzuki, Masahiro Aoshima, Koya Ariyoshi, Norichika Asoh, Tomoko Ishifuji, Naohisa Hamashige, Masahiko Abe, Peter Homel and Masayuki Ishida and has published in prestigious journals such as PLoS ONE, CHEST Journal and European Respiratory Journal.

In The Last Decade

Makito Yaegashi

29 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Makito Yaegashi Japan 14 455 123 88 79 72 30 722
Hiromasa Tachibana Japan 12 378 0.8× 132 1.1× 45 0.5× 56 0.7× 25 0.3× 55 552
Soledad Reyes Spain 14 551 1.2× 167 1.4× 35 0.4× 104 1.3× 43 0.6× 29 778
Nuanchan Prapphal Thailand 15 276 0.6× 281 2.3× 31 0.4× 62 0.8× 64 0.9× 51 563
Samuel Rhedin Sweden 13 356 0.8× 104 0.8× 53 0.6× 173 2.2× 64 0.9× 29 601
Iris De Schutter Belgium 17 443 1.0× 221 1.8× 206 2.3× 110 1.4× 75 1.0× 37 701
Adegoke G. Falade Nigeria 9 296 0.7× 108 0.9× 108 1.2× 52 0.7× 22 0.3× 19 497
N. Faelli Italy 13 335 0.7× 195 1.6× 75 0.9× 67 0.8× 33 0.5× 19 542
Mika Paldanius Finland 19 551 1.2× 131 1.1× 253 2.9× 106 1.3× 59 0.8× 40 1.0k
Delfino Legnani Italy 14 256 0.6× 349 2.8× 109 1.2× 47 0.6× 32 0.4× 36 686
D. Lieberman Israel 14 460 1.0× 140 1.1× 188 2.1× 65 0.8× 77 1.1× 21 774

Countries citing papers authored by Makito Yaegashi

Since Specialization
Citations

This map shows the geographic impact of Makito Yaegashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makito Yaegashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makito Yaegashi more than expected).

Fields of papers citing papers by Makito Yaegashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makito Yaegashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makito Yaegashi. The network helps show where Makito Yaegashi may publish in the future.

Co-authorship network of co-authors of Makito Yaegashi

This figure shows the co-authorship network connecting the top 25 collaborators of Makito Yaegashi. A scholar is included among the top collaborators of Makito Yaegashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makito Yaegashi. Makito Yaegashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dhoubhadel, Bhim Gopal, Tomoko Ishifuji, Makito Yaegashi, et al.. (2022). High prevalence of multiple serotypes of pneumococci in patients with pneumonia and their associated risk factors. Thorax. 77(11). 1121–1130. 4 indexed citations
3.
Maeda, Haruka, Bhim Gopal Dhoubhadel, Eiichiro Sando, et al.. (2022). Long-term impact of pneumococcal conjugate vaccines for children on adult pneumococcal pneumonia in Japan: Two multicenter observational studies from 2011 to 2020. Vaccine. 40(37). 5504–5512. 11 indexed citations
4.
Sando, Eiichiro, Motoi Suzuki, Masayuki Ishida, et al.. (2021). Definitive and Indeterminate Pseudomonas aeruginosa Infection in Adults with Community-acquired Pneumonia: A Prospective Observational Study. Annals of the American Thoracic Society. 18(9). 1475–1481. 13 indexed citations
5.
Hasegawa, Shinya, Atsushi Shiraishi, Makito Yaegashi, et al.. (2019). Ceftriaxone versus ampicillin/sulbactam for the treatment of aspiration-associated pneumonia in adults. Journal of Comparative Effectiveness Research. 8(15). 1275–1284. 13 indexed citations
6.
7.
Suzuki, Motoi, Naoko Katsurada, Minh Nhat Le, et al.. (2018). Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged ≥65 years in Japan. Vaccine. 36(21). 2960–2967. 15 indexed citations
8.
Sando, Eiichiro, et al.. (2018). Distinguishing Japanese Spotted Fever and Scrub Typhus, Central Japan, 2004– 2015. Emerging infectious diseases. 24(9). 1633–1641. 31 indexed citations
9.
Hamaguchi, Sugihiro, Motoi Suzuki, Masahiko Abe, et al.. (2018). Six underlying health conditions strongly influence mortality based on pneumonia severity in an ageing population of Japan: a prospective cohort study. BMC Pulmonary Medicine. 18(1). 88–88. 12 indexed citations
10.
Fujita, Koji, et al.. (2017). A case of tracheo‐innominate artery fistula successfully treated with endovascular stent of the innominate artery. Journal of General and Family Medicine. 18(4). 162–164. 6 indexed citations
11.
Suzuki, Motoi, Bhim Gopal Dhoubhadel, Tomoko Ishifuji, et al.. (2017). Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. The Lancet Infectious Diseases. 17(3). 313–321. 134 indexed citations
12.
Morimoto, Konosuke, Motoi Suzuki, Tomoko Ishifuji, et al.. (2015). The Burden and Etiology of Community-Onset Pneumonia in the Aging Japanese Population: A Multicenter Prospective Study. PLoS ONE. 10(3). e0122247–e0122247. 155 indexed citations
13.
Aoshima, Masahiro, Koya Ariyoshi, Norichika Asoh, et al.. (2014). The two years of prospective hospital based multicenter adult pneumonia surveillance in Japan; the final year report of APSG-Japan. European Respiratory Journal. 44(Suppl 58). P1054–P1054. 1 indexed citations
14.
15.
Hase, Ryota, et al.. (2014). Bacterial Meningitis in the Absence of Cerebrospinal Fluid Pleocytosis: A Case Report and Review of the Literature. Canadian Journal of Infectious Diseases and Medical Microbiology. 25(5). 249–251. 26 indexed citations
16.
Ogami, Takuya, et al.. (2012). A Case of Extreme Hypokalemia Whose Histologic Findings on Autopsy Resemble Distal Renal Tubular Acidosis. CHEST Journal. 142(4). 320A–320A. 1 indexed citations
17.
Yaegashi, Makito, et al.. (2006). The utility of the forced oscillation technique in assessing bronchodilator responsiveness in patients with asthma. Respiratory Medicine. 101(5). 995–1000. 16 indexed citations
18.
Akerman, Michael J., et al.. (2006). Bronchodilator Effect of Infused B-Type Natriuretic Peptide in Asthma. CHEST Journal. 130(1). 66–72. 18 indexed citations
19.
Yaegashi, Makito, et al.. (2005). Outcome of Morbid Obesity in the Intensive Care Unit. Journal of Intensive Care Medicine. 20(3). 147–154. 89 indexed citations
20.
Negishi, H., et al.. (1998). Prenatal diagnosis of limb-body wall complex.. PubMed. 43(8). 659–64. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiromasa Tachibana Breakdown of academic impact, for papers by Soledad Reyes Breakdown of academic impact, for papers by Nuanchan Prapphal Breakdown of academic impact, for papers by Samuel Rhedin Breakdown of academic impact, for papers by Iris De Schutter Breakdown of academic impact, for papers by Adegoke G. Falade Breakdown of academic impact, for papers by N. Faelli Breakdown of academic impact, for papers by Mika Paldanius Breakdown of academic impact, for papers by Delfino Legnani Breakdown of academic impact, for papers by D. Lieberman
Rankless by CCL
2026